Research > ETFs > ETF / ETP Commentary > 

Time for an Overseas Trip? Some Advisors Think So

At the start of each new year, there are regular predictions that international equity markets will outperform U.S. large-cap ones. Experts point to the relatively attractive valuation of Europe and Japan stocks compared to those in the U.S. However, when we look back, this outperfomance fails to happen. But will 2025 actually be different?The Vanguard FTSE Developed Markets ETF (VEA A) lagged behind the SPDR S&P 500 ETF (SPY A) in four of the last five calendar years. Only in 2022, when U.S. equities declined sharply did developed equity markets hold up better. However, VEA was up 6.3% year to date as of February 12, outpacing SPY’s 3.0% gain.Are You Underexposed to International Equities?Historically, many model portfolios had 20%-25% of assets dedicated to international equities to provide global diversification. However, after the strong run for the S&P 500 and other U.S. benchmarks the last few years, many people came into 2025 underexposed. In the first six weeks of 2025, we have seen some advisors leaning into developed international equity ETF. For example, the iShares Core MSCI International Developed Markets ETF (IDEV A-), the SPDR Developed World Ex-US ETF (SPDW A), and VEA all gathered more than $1 billion each. That’s encouraging.International Equity LandscapeThese ETFs are market-cap-weighted and cheap. SPDW and VEA have 0.03% expense ratios, following Vanguard’s recent fee cut. IDEV charges 0.04%. Yet there are differences. For example, SPDW and VEA have exposure to South Korea stocks like Samsung Electronics, while IDEV does not.   VEA is the largest international equity ETF, with over $140 billion in assets. The second-largest fund, the iShares Core MSCI EAFE ETF (IEFA A), has $125 billion, but it is primarily focused on developed Europe and Asia. Unlike IDEV, SPDW and VEA, IEFA does not have exposure to Canada stocks. Should You Turn to an Active Manager as Your International Equity Guide?While most of the assets invested in developed international equity ETFs are tracking an index, many actively managed products are now available from firms that advisors and investors have turned to for their U.S. equity exposure. The Avantis International Equity ETF (AVDE A) is a good example. The fund follows a similar approach as the Avantis U.S. Equity ETF (AVUS A). The Avantis approach is to overweight securities that management believes are trading at lower valuations with higher profitability ratios. The Avantis funds also tend to have low turnover rates and country and sector exposures similar to market-cap-weighted ETFs.Bottom-Up Approach Matters With Active International ETFsHowever, market-cap-weighted international ETFs have ASML and SAP as their two largest holdings, as of mid-February. Meanwhile, ADVE favored Novo Nordisk and Roche Holdings. The Dimensional International Core Equity 2 ETF (DFIC A-) and the JPMorgan International Research Enhanced Equity ETF (JIRE A) also offer benchmark-aware, well-diversified active ETFs. Meanwhile, the T. Rowe Price International Equity ETF (TOUS B) takes a more bottom-up approach than some of its active peers. The top 10 holdings for TOUS, as of mid-February, included Deutsche Telekom, Rolls Royce, and UniCredit, which are not similarly found in the market-cap index ETFs. TOUS was up 8.3% year to date, as of February 12. TOUS launched in 2023.New International ETF EntrantOne new active international equity ETF to watch is the Thornburg International Equity ETF (TXUE). The fund launched in January 2025, but the Thornburg name is likely familiar to many fans of active management. The ETF’s top holdings include E.ON, Orange, and Safran. Thornburg has a long and strong history of supporting international equity investors through mutual funds.  At the Exchange conference on March 24, we will be having a panel titled “International Equity: Time to reduce your home bias”. I hope to see you there. Are you registered? For more news, information, and strategy, visit ETFDB.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.